Suppr超能文献

[1985 - 1987年在象牙海岸进行的伊维菌素(美迪善)治疗人类盘尾丝虫病的疗效和耐受性研究。II. 根据大规模防治运动对每年或每半年口服单剂量100、150或200微克/千克的效果评估]

[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. II. Evaluation in the light of mass campaigns on the effect of yearly or half-yearly administration of single oral doses of 100, 150 or 200 mcg/kg].

作者信息

Larivière M, Beauvais B, Aziz M, Garin J F, Abeloos J, Derouin F, Bamba M, Ferly-Therizol M, Sarfati C, Basset D

机构信息

Faculté de Médecine Lariboisière-Saint-Louis, Laboratoire de Parasitologie-Mycologie, Paris, France.

出版信息

Bull Soc Pathol Exot Filiales. 1989 Jan;82(1):48-57.

PMID:2545367
Abstract

One hundred and twenty patients out of 220 in a previous study were retreated after 6 months or one year with doses of 100, 150 or 200 mcg/kg of ivermectin. The tolerance was excellent due probably to the small number of skin microfilariae obtained with the first treatment. The annual treatment with 150 to 200 mcg/kg, better than with 100 mcg/kg, keeps for the year following the second treatment the microfilariae number between 6 and 11% of the initial level. The half-yearly administration keeps it between 1 and 7% and especially 94 to 100% of these retreated patients have a level of microfilariae less than 5 mf/mg. The results obtained with the half-yearly treatment show a considerable reduction of the number of microfilariae in the anterior chamber of the eye and the percentage of positive patients. Ivermectin is a very efficient microfilaricidal drug for the treatment of onchocerciasis and the prevention of ocular complications. Its rational use in mass campaigns should reduce, if not interrupt, the transmission of this parasitic disease.

摘要

在之前的一项研究中,220名患者中有120名在6个月或1年后接受了100、150或200微克/千克剂量的伊维菌素再次治疗。耐受性良好,这可能是由于首次治疗后获得的皮肤微丝蚴数量较少。每年使用150至200微克/千克进行治疗,效果优于100微克/千克,在第二次治疗后的一年里,微丝蚴数量保持在初始水平的6%至11%之间。半年给药一次可使其保持在1%至7%之间,特别是这些接受再次治疗的患者中有94%至100%的微丝蚴水平低于5条/毫克。半年治疗的结果显示,眼前房微丝蚴数量和阳性患者百分比大幅降低。伊维菌素是一种治疗盘尾丝虫病和预防眼部并发症的非常有效的杀微丝蚴药物。在大规模防治运动中合理使用它,即使不能阻断这种寄生虫病的传播,也应能减少其传播。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验